These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 8597627)
21. Coordinate expression of activating Fc gamma receptors I and III and inhibiting Fc gamma receptor type II in the determination of joint inflammation and cartilage destruction during immune complex-mediated arthritis. Nabbe KC; Blom AB; Holthuysen AE; Boross P; Roth J; Verbeek S; van Lent PL; van den Berg WB Arthritis Rheum; 2003 Jan; 48(1):255-65. PubMed ID: 12528127 [TBL] [Abstract][Full Text] [Related]
22. Characterization of two subsets of human T gamma cells. van de Griend RJ; ten Berge I; Tanke HJ; Roos D; Schellekens PT; Melief CJ; Zeijlemaker WP; Astaldi A J Immunol; 1982 May; 128(5):1979-85. PubMed ID: 6977578 [TBL] [Abstract][Full Text] [Related]
23. Synthetic peptides from mouse Fc receptor (MoFc gamma RII) that alter the binding of IgG to MoFc gamma RII. Goldsmith EB; Erickson BW; Thompson NL Biochemistry; 1997 Jan; 36(4):952-9. PubMed ID: 9020795 [TBL] [Abstract][Full Text] [Related]
24. Cell type-specific glycoforms of Fc gamma RIIIa (CD16): differential ligand binding. Edberg JC; Kimberly RP J Immunol; 1997 Oct; 159(8):3849-57. PubMed ID: 9378972 [TBL] [Abstract][Full Text] [Related]
25. Characterization and crystallization of soluble human Fc gamma receptor II (CD32) isoforms produced in insect cells. Sondermann P; Jacob U; Kutscher C; Frey J Biochemistry; 1999 Jun; 38(26):8469-77. PubMed ID: 10387093 [TBL] [Abstract][Full Text] [Related]
27. Antigen topography is critical for interaction of IgG2 anti-red-cell antibodies with Fc gamma receptors. Kumpel BM; van de Winkel JG; Westerdaal NA; Hadley AG; Dugoujon JM; Blancher A Br J Haematol; 1996 Jul; 94(1):175-83. PubMed ID: 8757532 [TBL] [Abstract][Full Text] [Related]
28. Effect of proteolytic enzymes on neutrophil Fc gamma RII activity. Trevani AS; Andonegui GA; Isturiz MA; Schatner M; Serebrinsky G; Geffner JR Immunology; 1994 Aug; 82(4):632-7. PubMed ID: 7835928 [TBL] [Abstract][Full Text] [Related]
29. In vitro functional activity of IgG1 and IgG3 polyclonal and monoclonal anti-D. Kumpel BM Vox Sang; 1997; 72(1):45-51. PubMed ID: 9031501 [TBL] [Abstract][Full Text] [Related]
30. Comparison of the ability of red cells sensitized with a bispecific anti-D x anti-Fc gamma RIII Fab fragment to activate human K cells and peritoneal macrophages through Fc gamma RIII. Bakács T; Hadley AG; Kumpel BM; Segal DM; Banhidy F Immunol Lett; 1994 Sep; 42(1-2):91-5. PubMed ID: 7829136 [TBL] [Abstract][Full Text] [Related]
31. Human platelet Fc receptors: binding kinetics of Fc derivatives to the receptors. Shido K; Ahmad G; Hsu L; Kamiyama M J Clin Lab Immunol; 1995; 46(1):25-33. PubMed ID: 9363589 [TBL] [Abstract][Full Text] [Related]
32. On the interaction between agalactosyl IgG and Fc gamma receptors. Groenink J; Spijker J; van den Herik-Oudijk IE; Boeije L; Rook G; Aarden L; Smeenk R; van de Winkel JG; van den Broek MF Eur J Immunol; 1996 Jun; 26(6):1404-7. PubMed ID: 8647224 [TBL] [Abstract][Full Text] [Related]
33. Type I (CD64) and type II (CD32) Fc gamma receptor-mediated phagocytosis by human blood dendritic cells. Fanger NA; Wardwell K; Shen L; Tedder TF; Guyre PM J Immunol; 1996 Jul; 157(2):541-8. PubMed ID: 8752900 [TBL] [Abstract][Full Text] [Related]
34. Expression of GnTIII in a recombinant anti-CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FC gamma RIII. Davies J; Jiang L; Pan LZ; LaBarre MJ; Anderson D; Reff M Biotechnol Bioeng; 2001 Aug; 74(4):288-94. PubMed ID: 11410853 [TBL] [Abstract][Full Text] [Related]
35. Preclinical studies with Fc(gamma)R bispecific antibodies and granulocyte colony-stimulating factor-primed neutrophils as effector cells against HER-2/neu overexpressing breast cancer. Stockmeyer B; Valerius T; Repp R; Heijnen IA; Bühring HJ; Deo YM; Kalden JR; Gramatzki M; van de Winkel JG Cancer Res; 1997 Feb; 57(4):696-701. PubMed ID: 9044847 [TBL] [Abstract][Full Text] [Related]
36. Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptors. Stavenhagen JB; Gorlatov S; Tuaillon N; Rankin CT; Li H; Burke S; Huang L; Vijh S; Johnson S; Bonvini E; Koenig S Cancer Res; 2007 Sep; 67(18):8882-90. PubMed ID: 17875730 [TBL] [Abstract][Full Text] [Related]
37. Multiple interactions of IgG with its core oligosaccharide can modulate recognition by complement and human Fc gamma receptor I and influence the synthesis of its oligosaccharide chains. Lund J; Takahashi N; Pound JD; Goodall M; Jefferis R J Immunol; 1996 Dec; 157(11):4963-9. PubMed ID: 8943402 [TBL] [Abstract][Full Text] [Related]
38. IFN-gamma treated monocyte/macrophage phagocytosis of red cells sensitized with IgG1 and IgG3 Anti-D containing identical immunoglobulin variable region genes. Perri D; Shabani F; Ziaeian G; Denomme GA Transfus Apher Sci; 2008 Aug; 39(1):37-44. PubMed ID: 18614400 [TBL] [Abstract][Full Text] [Related]
39. Functional mapping of the Fc gamma RII binding site on human IgG1 by synthetic peptides. Medgyesi D; Uray K; Sallai K; Hudecz F; Koncz G; Abramson J; Pecht I; Sármay G; Gergely J Eur J Immunol; 2004 Apr; 34(4):1127-35. PubMed ID: 15048724 [TBL] [Abstract][Full Text] [Related]
40. A human anti-D monoclonal antibody selected for enhanced FcgammaRIII engagement clears RhD+ autologous red cells in human volunteers as efficiently as polyclonal anti-D antibodies. Beliard R; Waegemans T; Notelet D; Massad L; Dhainaut F; Romeuf Cd; Guemas E; Haazen W; Bourel D; Teillaud JL; Prost JF Br J Haematol; 2008 Apr; 141(1):109-19. PubMed ID: 18279459 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]